Authors: Harhangi, BS Oostra, BA Heutink, P van Duijn, CM Hofman, A Breteler, MMB

Citation: Bs. Harhangi et al., CYP2D6 polymorphism in Parkinson's disease: The Rotterdam study, MOVEMENT D, 16(2), 2001, pp. 290-293

Authors: Lucking, CB Durr, A Bonifati, V Vaughan, J De Michele, G Gasser, T Harhangi, BS Meco, G Denefle, P Wood, NW Agid, Y Brice, A

Citation: Cb. Lucking et al., Association between early-onset Parkinson's disease and mutations in the parkin gene, N ENG J MED, 342(21), 2000, pp. 1560-1567

Authors: Harhangi, BS de Rijk, MC van Duijn, CM Van Broeckhoven, C Hofman, A Breteler, MMB

Citation: Bs. Harhangi et al., APOE and the risk of PD with or without dementia in a population-based study, NEUROLOGY, 54(6), 2000, pp. 1272-1276

Authors: Abbas, N Lucking, CB Ricard, S Durr, A Bonifati, V De Michele, G Bouley, S Vaughan, JR Gasser, T Marconi, R Broussolle, E Brefel-Courbon, C Harhangi, BS Oostra, AB Fabrizio, E Bohme, GA Pradier, L Wood, NW Filla, A Meco, G Denefle, P Agid, Y Brice, A

Citation: N. Abbas et al., A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe, HUM MOL GEN, 8(4), 1999, pp. 567-574

Authors: Harhangi, BS Farrer, MJ Lincoln, S Bonifati, V Meco, G De Michele, G Brice, A Durr, A Martinez, M Gasser, T Bereznai, B Vaughan, JR Wood, NW Hardy, J Oostra, BA Breteler, MMB

Citation: Bs. Harhangi et al., The lle93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease, NEUROSCI L, 270(1), 1999, pp. 1-4

Authors: Harhangi, BS Oostra, BA Heutink, P van Duijn, CM Hofman, A Breteler, MMB

Citation: Bs. Harhangi et al., N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study, J NE NE PSY, 67(4), 1999, pp. 518-520